The COVID-19 pandemic proved highly consequential for the pharmaceutical industry as public debate around vaccine and drug development reached a fever pitch. But under the surface, this black swan event expedited the implementation of underutilized digital capabilities, like real-world data (RWD) and decentralized clinical trials (DCTs). This report helps healthcare leaders understand and approach the most critical age-of-the-customer trends that will impact the industry in 2022.